• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的死亡率:对地理和时间变化的重新审视。

Mortality rates from multiple sclerosis: geographical and temporal variations revisited.

作者信息

Williams E S, Jones D R, McKeran R O

机构信息

Department of Public Health Medicine, Croydon General Hospital, UK.

出版信息

J Neurol Neurosurg Psychiatry. 1991 Feb;54(2):104-9. doi: 10.1136/jnnp.54.2.104.

DOI:10.1136/jnnp.54.2.104
PMID:2019834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1014342/
Abstract

A review of the United Kingdom (UK) multiple sclerosis (MS) literature suggests that over the last three decades prevalence and estimated incidence rates have increased, while mortality rates have been declining. UK mortality data over a 30 year period have been studied to examine temporal and geographical variations, to estimate changes in survival, and to examine the relationship between mortality and morbidity trends. The study has shown an overall decline in mortality throughout the UK of approximately 25% over the 30 year period ending in 1983, and a reduction in the mortality differential between Scotland, and England and Wales, but no positive correlation has been found between mortality and morbidity. The overall decline in death rate in females was 23% and in males 30% over the 30 years of the survey. The total number of deaths declined by 39% between the five year periods 1954-58 and 1979-83 in Scotland compared with a 10% decline for England and Wales. Estimated median age of death increased from 52 to 59 years and the improvement in survival over the period of study was similar for both countries and is unlikely to have contributed to the reduction in mortality differential. Within England and Wales regional mortality rates did not show a clear north-south gradient. The decline in the mortality differential between Scotland and England (if not artefactual) may provide an important aetiological clue in the search for the cause of multiple sclerosis, and the rate of decline suggests an environmental rather than a genetic aetiology.

摘要

对英国多发性硬化症(MS)文献的综述表明,在过去三十年中,患病率和估计发病率有所上升,而死亡率则在下降。对英国30年期间的死亡率数据进行了研究,以考察时间和地理差异,估计生存率的变化,并研究死亡率与发病率趋势之间的关系。该研究表明,在截至1983年的30年期间,英国的总体死亡率下降了约25%,苏格兰与英格兰和威尔士之间的死亡率差异有所缩小,但未发现死亡率与发病率之间存在正相关。在调查的30年中,女性的死亡率总体下降了23%,男性下降了30%。与英格兰和威尔士下降10%相比,苏格兰1954 - 58年至1979 - 83年这两个五年期之间的死亡总数下降了39%。估计的死亡年龄中位数从52岁增加到59岁,在研究期间两个国家的生存率改善情况相似,而且这一情况不太可能是导致死亡率差异缩小的原因。在英格兰和威尔士内部,地区死亡率并未呈现明显的南北梯度。苏格兰与英格兰之间死亡率差异的缩小(如果不是人为造成的)可能为寻找多发性硬化症病因提供重要的病因线索,而且下降速度表明其病因是环境因素而非遗传因素。

相似文献

1
Mortality rates from multiple sclerosis: geographical and temporal variations revisited.多发性硬化症的死亡率:对地理和时间变化的重新审视。
J Neurol Neurosurg Psychiatry. 1991 Feb;54(2):104-9. doi: 10.1136/jnnp.54.2.104.
2
The distribution of multiple sclerosis in the United Kingdom.英国多发性硬化症的分布情况。
J Neurol Neurosurg Psychiatry. 1986 Oct;49(10):1115-24. doi: 10.1136/jnnp.49.10.1115.
3
Multiple sclerosis distribution in England and Wales and parts of Europe.多发性硬化症在英格兰、威尔士及欧洲部分地区的分布情况。
J Hyg (Lond). 1971 Sep;69(3):373-89. doi: 10.1017/s0022172400021628.
4
Mortality from multiple sclerosis in Austria 1970-2001: dynamics, trends, and prospects.1970 - 2001年奥地利多发性硬化症死亡率:动态变化、趋势及前景
Eur J Neurol. 2004 Aug;11(8):511-20. doi: 10.1111/j.1468-1331.2004.00818.x.
5
The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland.英格兰、威尔士及爱尔兰共和国运动神经元病和多发性硬化症死亡率的变化情况。
Neuroepidemiology. 1992;11(4-6):236-43. doi: 10.1159/000110936.
6
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
7
Small intestinal cancer in England & Wales and Scotland: time trends in incidence, mortality and survival.英格兰、威尔士和苏格兰的小肠癌:发病率、死亡率和生存率的时间趋势
Aliment Pharmacol Ther. 2006 May 1;23(9):1297-306. doi: 10.1111/j.1365-2036.2006.02891.x.
8
Morbidity and mortality in motor neuron disease: comparison with multiple sclerosis and Parkinson's disease: age and sex specific rates and cohort analyses.运动神经元病的发病率和死亡率:与多发性硬化症和帕金森病的比较:年龄和性别特异性率及队列分析。
J Neurol Neurosurg Psychiatry. 1985 Apr;48(4):320-7. doi: 10.1136/jnnp.48.4.320.
9
The contribution of mortality statistics to the study of multiple sclerosis in Australia.死亡率统计数据对澳大利亚多发性硬化症研究的贡献。
J Neurol Neurosurg Psychiatry. 1989 Jan;52(1):1-7. doi: 10.1136/jnnp.52.1.1.
10
Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales.澳大利亚、新西兰和南非与英格兰及威尔士的运动神经元病和多发性硬化症死亡率比较。
J Neurol Neurosurg Psychiatry. 1993 Jun;56(6):633-7. doi: 10.1136/jnnp.56.6.633.

引用本文的文献

1
Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases.血清生物标志物和患者年龄在炎症性脱髓鞘疾病中的临床意义。
Ann Clin Transl Neurol. 2020 Jun;7(6):992-1001. doi: 10.1002/acn3.51070. Epub 2020 Jun 4.
2
Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database.1990-2010 年英国多发性硬化症的发病率和患病率:一般实践研究数据库中的描述性研究。
J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):76-84. doi: 10.1136/jnnp-2013-305450. Epub 2013 Sep 19.
3
Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.1979-2006 年英国人群多发性硬化症、运动神经元病、帕金森病和癫痫的死亡证明趋势。
J Neurol. 2010 May;257(5):706-15. doi: 10.1007/s00415-009-5392-z. Epub 2009 Nov 28.
4
The prevalence of multiple sclerosis in the Leeds Health Authority.利兹卫生局辖区内多发性硬化症的患病率。
J Neurol Neurosurg Psychiatry. 1998 May;64(5):605-10. doi: 10.1136/jnnp.64.5.605.
5
Prevalence of multiple sclerosis in Rochdale.罗奇代尔多发性硬化症的患病率。
J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):415-7. doi: 10.1136/jnnp.61.4.415.
6
Multiple sclerosis in the north Cambridgeshire districts of East Anglia.东盎格利亚剑桥郡北部地区的多发性硬化症
J Neurol Neurosurg Psychiatry. 1996 Jul;61(1):121. doi: 10.1136/jnnp.61.1.121.
7
Surveying multiple sclerosis in the United Kingdom.英国多发性硬化症调查
J Neurol Neurosurg Psychiatry. 1995 Jan;58(1):2-6. doi: 10.1136/jnnp.58.1.2.
8
Multiple sclerosis in the Cambridge health district of east Anglia.东安格利亚剑桥健康区的多发性硬化症
J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):877-82. doi: 10.1136/jnnp.55.10.877.

本文引用的文献

1
The geographic distribution of multiple sclerosis and its estimated prevalence in the United States.多发性硬化症在美国的地理分布及其估计患病率。
Res Publ Assoc Res Nerv Ment Dis. 1950;28:15-24.
2
EPIDEMIOLOGY OF MULTIPLE SCLEROSIS IN THE COUNTIES OF NORTHUMBERLAND AND DURHAM.诺森伯兰郡和达勒姆郡的多发性硬化症流行病学
J Neurol Neurosurg Psychiatry. 1963 Aug;26(4):368-76. doi: 10.1136/jnnp.26.4.368.
3
Epidemiological studies in Cornwall.康沃尔郡的流行病学研究。
Proc R Soc Med. 1961 Mar;54(3):209-16. doi: 10.1177/003591576105400307.
4
Observations on the prevalence of multiple sclerosis in Northern Scotland.苏格兰北部多发性硬化症患病率观察
Brain. 1956 Dec;79(4):635-54. doi: 10.1093/brain/79.4.635.
5
Prevalence of disseminated sclerosis in Northern Ireland.北爱尔兰播散性硬化症的患病率。
Ulster Med J. 1954 Mar;23(Suppl. 2):1-27.
6
Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology.奥克尼群岛和设得兰群岛的多发性硬化症。I:流行病学、临床因素及方法学
J Epidemiol Community Health. 1980 Dec;34(4):229-39. doi: 10.1136/jech.34.4.229.
7
A further prevalence study of multiple sclerosis in north-east Scotland.苏格兰东北部多发性硬化症的进一步患病率研究。
J Neurol Neurosurg Psychiatry. 1980 Apr;43(4):310-5. doi: 10.1136/jnnp.43.4.310.
8
The analysis of mortality by the subject-years method.采用受试者年数法进行死亡率分析。
Biometrics. 1983 Mar;39(1):173-84.
9
Prevalence of disseminated sclerosis in the Faroes, the Orkneys and Shetland.法罗群岛、奥克尼群岛和设得兰群岛播散性硬化症的患病率。
Acta Neurol Scand. 1966;42(S19):9-11. doi: 10.1111/j.1600-0404.1966.tb01996.x.
10
An alternative approach to statistical age-period-cohort analysis.统计年龄-时期-队列分析的另一种方法。
J Chronic Dis. 1985;38(10):831-40. doi: 10.1016/0021-9681(85)90106-7.